Billings Clinic
Especially For:

Clinical Trials

Title   Bladder Cancer: S0337 Intravesical Gemcitabine in Patients with Superficial Bladder Cancer
Description   SWOG S0337 Phase II Study of Intravesical Gemcitabine in Patients with Superficial Bladder Cancer who progress despite intravesical BCG.
IRB Number   S0337
Category   Bladder Cancer
Inclusion/Notes   Must have received at least two privious courses of Intravesical BCG and No concurrent Ratiation Therapy.
Status   Active
Start Date   12/08/2006
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.